Complete response to azacitidine priming and nab-paclitaxel in non-Hodgkin lymphoma resistant to biochemotherapy

The standard of care for first-line therapy in diffuse large B-cell lymphoma (DLBCL) is the rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) regimen. For patients who fail to respond, have an incomplete response or relapse, numerous effective options exists besides salva...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Clin Oncol
Main Authors: Bowen, Randy C., Hahn, Andrew W., Butler, Thomas W., Khong, Hung T.
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2017
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5245156/
https://ncbi.nlm.nih.gov/pubmed/28123744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.1090
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker